Order of the Court (Eighth Chamber) of 14 November 2013.
Astrazeneca AB v Comptroller General of Patents, Designs and Trade Marks.
Reference for a preliminary ruling: High Court of Justice (England & Wales), Chancery Division (Patents Court) - United Kingdom.
Medicinal products for human use - Supplementary protection certificate - Regulation (EC) No 469/2009 - Article 13(1) - Concept of ‘first authorisation to place [a product] on the market in the Community’ - Authorisation issued by the Swiss Institute for Medicinal Products (Swissmedic) - Automatic recognition in Liechtenstein - Authorisation issued by the European Medicines Agency - Period of validity of a certificate.
Reports of Cases
Error, this information cannot be found
Links to the texts